PRVB logo

Provention Bio (PRVB) Cash From Financing

Annual CFF

$129.38 M
+$27.01 M+26.38%

31 December 2022

PRVB Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFF

$905.00 K
-$113.79 M-99.21%

31 December 2022

PRVB Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFF

$129.38 M
+$905.00 K+0.70%

31 December 2022

PRVB TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PRVB Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+13.2%+100.0%+26.0%
5 y5 years+118.0%-98.6%+105.7%

PRVB Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat high-99.2%-40.2%

Provention Bio Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2022
$129.38 M(+26.4%)
$905.00 K(-99.2%)
$129.38 M(+0.7%)
Sept 2022
-
$114.69 M(+885.8%)
$128.48 M(+832.0%)
June 2022
-
$11.63 M(+441.2%)
$13.79 M(+541.2%)
Mar 2022
-
$2.15 M(>+9900.0%)
$2.15 M(-97.9%)
Dec 2021
$102.38 M(-10.4%)
$0.00(0.0%)
$102.38 M(-0.3%)
Sept 2021
-
$0.00(0.0%)
$102.67 M(-0.3%)
June 2021
-
$0.00(-100.0%)
$102.95 M(-52.4%)
Mar 2021
-
$102.38 M(>+9900.0%)
$216.47 M(+89.4%)
Dec 2020
$114.29 M
$291.00 K(+1.4%)
$114.29 M(+0.2%)
Sept 2020
-
$287.00 K(-99.7%)
$114.07 M(-35.4%)
June 2020
-
$113.52 M(>+9900.0%)
$176.63 M(+179.8%)
DateAnnualQuarterlyTTM
Mar 2020
-
$194.00 K(+173.2%)
$63.13 M(+0.3%)
Dec 2019
$62.94 M(+6.1%)
$71.00 K(-99.9%)
$62.94 M(+0.1%)
Sept 2019
-
$62.85 M(>+9900.0%)
$62.89 M(+4.7%)
June 2019
-
$21.00 K(>+9900.0%)
$60.05 M(+1.2%)
Mar 2019
-
$0.00(-100.0%)
$59.35 M(0.0%)
Dec 2018
$59.35 M(+122.1%)
$20.00 K(-100.0%)
$59.35 M(+0.0%)
Sept 2018
-
$60.01 M(-8911.7%)
$59.33 M(-8824.7%)
June 2018
-
-$681.00 K(<-9900.0%)
-$680.00 K(-102.5%)
Dec 2017
$26.72 M
$1000.00(>+9900.0%)
$26.72 M(+0.0%)
Sept 2017
-
$0.00(-100.0%)
$26.71 M(0.0%)
June 2017
-
$26.71 M
$26.71 M

FAQ

  • What is Provention Bio annual cash flow from financing activities?
  • What is the all time high annual CFF for Provention Bio?
  • What is Provention Bio quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Provention Bio?
  • What is Provention Bio TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Provention Bio?

What is Provention Bio annual cash flow from financing activities?

The current annual CFF of PRVB is $129.38 M

What is the all time high annual CFF for Provention Bio?

Provention Bio all-time high annual cash flow from financing activities is $129.38 M

What is Provention Bio quarterly cash flow from financing activities?

The current quarterly CFF of PRVB is $905.00 K

What is the all time high quarterly CFF for Provention Bio?

Provention Bio all-time high quarterly cash flow from financing activities is $114.69 M

What is Provention Bio TTM cash flow from financing activities?

The current TTM CFF of PRVB is $129.38 M

What is the all time high TTM CFF for Provention Bio?

Provention Bio all-time high TTM cash flow from financing activities is $216.47 M